Cited by 1,973Cancer Cells and MetastasisBreast Cancer Treatment Studies3D Printing in Biomedical Research

The DOI matches its Crossref record; 75 of the 79 references it cites were found in a registry or an index.

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Open access

Sachs, Norman, de Ligt, Joep, Kopper, Oded, Gogola, Ewa, Bounova, Gergana, Weeber, Fleur, Balgobind, Anjali Vanita, Wind, Karin, Gracanin, Ana, Begthel, Harry, Korving, Jeroen, van Boxtel, Ruben, Duarte, Alexandra Alves, Lelieveld, Daphne, van Hoeck, Arne, Ernst, Robert Frans, Blokzijl, Francis, Nijman, Isaac Johannes, Hoogstraat, Marlous, van de Ven, Marieke, Egan, David Anthony, Zinzalla, Vittoria, Moll, Jurgen, Boj, Sylvia Fernandez, Voest, Emile Eugene, Wessels, Lodewyk, van Diest, Paul Joannes, Rottenberg, Sven, Vries, Robert Gerhardus Jacob, Cuppen, Edwin, Clevers, Hans·2018·Cell

DOI 10.1016/j.cell.2017.11.010

Open this paper in CoChat — free account Open PDF

Abstract

Breast cancer (BC) comprises multiple distinct subtypes that differ genetically, pathologically, and clinically. Here, we describe a robust protocol for long-term culturing of human mammary epithelial organoids. Using this protocol, >100 primary and metastatic BC organoid lines were generated, broadly recapitulating the diversity of the disease. BC organoid morphologies typically matched the histopathology, hormone receptor status, and HER2 status of the original tumor. DNA copy number variations as well as sequence changes were consistent within tumor-organoid pairs and largely retained even after extended passaging. BC organoids furthermore populated all major gene-expression-based classification groups and allowed in vitro drug screens that were consistent with in vivo xeno-transplantations and patient response. This study describes a representative collection of well-characterized BC organoids available for cancer research and drug development, as well as a strategy to assess in vitro drug response in a personalized fashion.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2017.11.010

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w 1118 ; iso-2; iso-3
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502

Show all 79 references

Research works printed but not linked: 1

Blokzijl, 2016, MutationalPatterns: an integrative R package for studying patterns in base substitution catalogues, bioRxiv

Sorted by citations

Items 501–600 of 1,002

Clinical trials in-a-dish for cardiovascular medicine
Wu, X., Swanson, K., Yıldırım, Z., Liu, W., Liao, R., & Wu, J. C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae519 · Cited by 42
Biomaterial-assisted organoid technology for disease modeling and drug screening
Shao, Y., Wang, J., Jin, A., Jiang, S., Lei, L., & Liu, L. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101438 · Cited by 45
Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
Li, X., Pan, B., Song, X., Li, N., Zhao, D., Li, M., & Zhao, Z. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01171-5 · Cited by 39
Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer
Gustafsson, A., Garré, E., Leiva, M. C., Salerno, S., Ståhlberg, A., & Landberg, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-92724-9 · Cited by 39
Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
Yang, J., Huang, S., Cheng, S., Jin, Y., Zhang, N., & Wang, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701429 · Cited by 40
Fourier light-field imaging of human organoids with a hybrid point-spread function
Liu, W., Kim, G.-A. R., Takayama, S., & Jia, S. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114201 · Cited by 40
Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy
Wu, W., Li, X., & Yu, S. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.04.050 · Cited by 40
Systematic review: predictive value of organoids in colorectal cancer
Sakshaug, B. C., Folkesson, E., Haukaas, T. H., Visnes, T., & Flobak, Å. (2023) · Scientific Reports · doi:10.1038/s41598-023-45297-8 · Cited by 40
High-Throughput Assessment of Kinome-Wide Activation States
Schmidlin, T., Debets, D. O., van Gelder, C. A. G. H., Stecker, K. E., Rontogianni, S., van den Eshof, B. L., Kemper, K., Lips, E. H., van den Biggelaar, M., Peeper, D. S., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2019.08.005 · Cited by 36
A new interval differential equation for edge detection and determining breast cancer regions in mammography images
Guo, G., & Razmjooy, N. (2019) · Systems Science & Control Engineering · doi:10.1080/21642583.2019.1681033 · Cited by 38
Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies
Tanaka, N., Kanatani, S., Kaczyńska, D., Fukumoto, K., Louhivuori, L. M., Mizutani, T., Kopper, O., Kronqvist, P., Robertson, S., Lindh, C., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0576-z · Cited by 38
Self-citation
Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer
Lee, T. W., Lai, A., Harms, J. K., Singleton, D. C., Dickson, B. D., Macann, A., Hay, M. P., & Jamieson, S. M. F. (2020) · Cancers · doi:10.3390/cancers12123743 · Cited by 38
The Translational Application of Hydrogel for Organoid Technology: Challenges and Future Perspectives
Ma, P., Chen, Y., Lai, X., Zheng, J., Ye, E., Loh, X. J., Zhao, Y., Parikh, B. H., Su, X., You, M., et al. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202100191 · Cited by 39
In vitro assays for investigating the FLASH effect
Adrian, G., Ruan, J.-L., Paillas, S., Cooper, C. R., & Petersson, K. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.5 · Cited by 38
Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors
Choi, B.-H., Rawat, V., Högström, J., Burns, P. A., Conger, K. O., Özgürses, M. E., Patel, J. M., Mehta, T. S., Warren, A., Selfors, L. M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110278 · Cited by 38
Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling
Würth, R., Donato, E., Michel, L. L., Saini, M., Becker, L., Cheytan, T., Doncevic, D., Meßmer, T., Gutjahr, E., Weber, R., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00882-2 · Cited by 37
Quantitative Spatial Analysis of Metabolic Heterogeneity Across in vivo and in vitro Tumor Models
Heaster, T. M., Landman, B. A., & Skala, M. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01144 · Cited by 36
Sample preparation strategies for high‐throughput mass spectrometry imaging of primary tumor organoids
Johnson, J., Sharick, J. T., Skala, M. C., & Li, L. (2019) · Journal of Mass Spectrometry · doi:10.1002/jms.4452 · Cited by 37
Mammary Organoids and 3D Cell Cultures: Old Dogs with New Tricks
Sumbal, J., Budková, Z., Traustadóttir, G. Á., & Koledova, Z. S. (2020) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09468-x · Cited by 41
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer
Parsyan, A. E., Cruickshank, J., Hodgson, K., Wakeham, D., Pellizzari, S., Bhat, V., & Cescon, D. W. (2021) · The Breast · doi:10.1016/j.breast.2021.03.011 · Cited by 37
tRNA biogenesis and specific aminoacyl-tRNA synthetases regulate senescence stability under the control of mTOR
Guillon, J., Coquelet, H., Leman, G., Toutain, B., Petit, C., Henry, C., Boissard, A., Guette, C., & Coqueret, O. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009953 · Cited by 36
Targeting cancer drug resistance utilizing organoid technology
Chai, C., Ji, P., Xu, H., Tang, H., Wang, Z., Zhang, H., & Zhou, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114098 · Cited by 35
Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Cheng, X., Sun, Y., Highkin, M. K., Vemalapally, N., Jin, X., Zhou, B., Prior, J. L., Tipton, A. R., Li, S., Iliuk, A. B., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3558 · Cited by 38
Decoding the basis of histological variation in human cancer
Fujii, M., Sekine, S., & Sato, T. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00648-5 · Cited by 35
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer
Zhang, Y., Zhou, S., Kai, Y., Zhang, Y.-Q., Peng, C., Li, Z., Jameel, M., Belmar, J., Zheng, X., Ma, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49875-w · Cited by 37
Organoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 37
Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling
Dzobo, K., Rowe, A., Senthebane, D. A., AlMazyadi, M., Patten, V. A., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0172 · Cited by 37
Organoids: Past Learning and Future Directions
O’Connell, L., & Winter, D. C. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0227 · Cited by 39
Sporadic activation of an oxidative stress–dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies
Pereira, E. J., Burns, J. S., Lee, C. Y., Marohl, T., Calderon, D., Wang, L., Atkins, K. A., Wang, C., & Janes, K. A. (2020) · Science Signaling · doi:10.1126/scisignal.aba4200 · Cited by 36
Food-Derived Pharmacological Modulators of the Nrf2/ARE Pathway: Their Role in the Treatment of Diseases
Zhao, F., Ci, X., Man, X., Li, J., Wei, Z., & Zhang, S. (2021) · Molecules · doi:10.3390/molecules26041016 · Cited by 38
Tissues and Tumor Microenvironment (TME) in 3D: Models to Shed Light on Immunosuppression in Cancer
Ho, T., & Msallam, R. (2021) · Cells · doi:10.3390/cells10040831 · Cited by 39
Drug screening by uniform patient derived colorectal cancer hydro-organoids
Jung, Y. H., Choi, D., Park, K., Lee, S.-B., Kim, J., Kim, H., Jeong, H., Yang, J. H., Kim, J., Chung, S. H., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121004 · Cited by 35
Immuno-genomic classification of colorectal cancer organoids reveals cancer cells with intrinsic immunogenic properties associated with patient survival
Cho, E. J., Kim, M., Jo, D., Kim, J., Oh, J., Chung, H. C., Lee, S.-H., Kim, D., Chun, S., Kim, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02034-1 · Cited by 36
In vitro models of the human heart
Hofbauer, P., Jahnel, S. M., & Mendjan, S. (2021) · Development · doi:10.1242/dev.199672 · Cited by 39
Current Status of Breast Organoid Models
Mohan, S. C., Lee, T.-Y., Giuliano, A. E., & Cui, X. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.745943 · Cited by 39
Patient-derived cancer models: Valuable platforms for anticancer drug testing
Genta, S., Coburn, B. A., Cescon, D. W., & Spreafico, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.976065 · Cited by 39
Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine
Spagnol, G., Sensi, F., Tommasi, O. D., Marchetti, M., Bonaldo, G., Xhindoli, L., Noventa, M., Agostini, M., Tozzi, R., & Saccardi, C. (2023) · Cancers · doi:10.3390/cancers15072059 · Cited by 38
The role of patient-derived ovarian cancer organoids in the study of PARP inhibitors sensitivity and resistance: from genomic analysis to functional testing
Tao, M., & Wu, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02139-7 · Cited by 35
Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes
Al‐Hamaly, M. A., Turner, L. T., Rivera-Martinez, A., Rodriguez, A., & Blackburn, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032288 · Cited by 36
Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective
Ortiz, M. M. O., & Andrechek, E. R. (2023) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-023-09540-2 · Cited by 35
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
Choi, W., Kim, Y., Woo, S. M., Yu, Y., Lee, M. R., Lee, W. J., Chun, J. W., Sim, S. H., Chae, H., Shim, H., et al. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2022.1630 · Cited by 40
Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients
Wu, H., Wang, W., Zhang, Y., Chen, Y., Shan, C., Li, J., Jia, Y., Li, C., Du, C., Cai, Y., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34931 · Cited by 36
A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses
Raffo‐Romero, A., Ziane-Chaouche, L., Salomé‐Desnoulez, S., Hajjaji, N., Fournier, I., Salzet, M., & Duhamel, M. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100792 · Cited by 36
A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer
Çetįn, M., Saatci, Ö., Rezaeian, A.-H., Rao, C. N. R., Beneker, C. M., Sreenivas, K., Taylor, H. B., Pederson, B., Chatzistamou, I., Buckley, B., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.06.012 · Cited by 39
Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management
Chen, X., Shen, J., Jiang, X., Pan, M., Chang, S., Li, J., Wang, L., Miao, M., Feng, X., Zhang, L., et al. (2024) · Theranostics · doi:10.7150/thno.102318 · Cited by 36
Pituitary Remodeling Throughout Life: Are Resident Stem Cells Involved?
Laporte, E., Vennekens, A., & Vankelecom, H. E. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.604519 · Cited by 41
Acoustic Droplet-Assisted Superhydrophilic–Superhydrophobic Microarray Platform for High-Throughput Screening of Patient-Derived Tumor Spheroids
Xia, Y., Chen, H., Li, J., Hu, H., Qian, Q., He, R.-X., Ding, Z., & Guo, S.-S. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c06655 · Cited by 35
Regenerative Engineering: Current Applications and Future Perspectives
Goldenberg, D., McLaughlin, C., Koduru, S. V., & Ravnic, D. J. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.731031 · Cited by 37
An Optimized Workflow for the Analysis of Metabolic Fluxes in Cancer Spheroids Using Seahorse Technology
Campioni, G., Pasquale, V., Busti, S., Ducci, G., Sacco, E., & Vanoni, M. (2022) · Cells · doi:10.3390/cells11050866 · Cited by 36
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities
Esposito, R., Polidori, T., Meise, D. F., Pulido-Quetglas, C., Chouvardas, P., Forster, S., Schaerer, P., Kobel, A., Schlatter, J., Kerkhof, E., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100171 · Cited by 35
Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncology
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Organoids in cancer research: a review for pathologist‐scientists
Wood, L. D., & Ewald, A. J. (2021) · The Journal of Pathology · doi:10.1002/path.5684 · Cited by 35
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
McGrail, D. J., Pilie, P. G., Dai, H., Lam, T., Liang, Y., Voorwerk, L., Kok, M., Zhang, X. H.-F., Rosen, J. M., Heimberger, A. B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe6201 · Cited by 36
Engineering cell heterogeneity into organs-on-a-chip
Mertz, D. R., Ahmed, T., & Takayama, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00413g · Cited by 33
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges
Gao, J., Lan, J., Liao, H., Yang, F., Qiu, P., Jin, F., Wang, S., Shen, L., Chao, T., Zhang, C., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11434-9 · Cited by 37
Tumour organoids and assembloids: Patient‐derived cancer avatars for immunotherapy
Mei, J., Liu, X., Tian, H., Chen, Y., Cao, Y., Zeng, J., Liu, Y., Chen, Y., Gao, Y., Yin, J., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1656 · Cited by 34
Decellularized extracellular matrix for organoid and engineered organ culture
Guo, X., Liu, B., Zhang, Y., Cheong, S., Xu, T., Lu, F., & He, Y. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241300386 · Cited by 44
Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential
Karolak, A. M., Poonja, S., & Rejniak, K. A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007214 · Cited by 33
Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
Driehuis, E., Oosterom, N., Heil, S. G., Muller, I. B., Lin, M., Kolders, S., Jansen, G., de Jonge, R., Pieters, R., Clevers, H. C., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231588 · Cited by 37
Self-citation
Three-Dimensional Culture Systems in Gastric Cancer Research
Alzeeb, G., Metges, J., Corcos, L., & Jossic-Corcos, C. L. (2020) · Cancers · doi:10.3390/cancers12102800 · Cited by 38
3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis
Rao, S., Hossain, T., & Mahmoudi, T. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.024 · Cited by 34
Emerging liver organoid platforms and technologies
Lam, D. T. U. H., Dan, Y. Y., Chan, Y.-S., & Ng, H. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00089-1 · Cited by 36
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
Spelier, S., de Poel, E., Ithakisiou, G. N., Suen, S. W. F., Hagemeijer, M. C., Muilwijk, D., Vonk, A. M., Brunsveld, J. E., Kruisselbrink, E., van der Ent, C. K., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00495-2022 · Cited by 38
Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening
Zhang, S., Shen, J., Wang, X., Sun, X., Wu, Y., Zhang, M., Wang, R., & Hu, K. (2023) · Open Research (University of Surrey) · doi:10.1002/viw.20230010 · Cited by 33
Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
Lin, M., Gao, M., Cavnar, M. J., & Kim, J. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i7.509 · Cited by 33
Mapping oncogenic protein interactions for precision medicine
Tabar, M. S., Francis, H., Yeo, D., Bailey, C. G., & Rasko, J. E. J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33954 · Cited by 30
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 33
Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine
Li, Z., Li, Q., Zhou, C., Lu, K., Liu, Y., Xuan, L., & Wang, X. (2023) · Biomicrofluidics · doi:10.1063/5.0171350 · Cited by 33
Programming temporal stiffness cues within extracellular matrix hydrogels for modelling cancer niches
Major, G. S., Ahn, M., Cho, W.-W., Santos, M., Wise, J., Phillips, E., Wise, S. G., Jang, J., Rnjak‐Kovacina, J., Woodfield, T. B. F., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101004 · Cited by 32
LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6A modification in triple‐negative breast cancer
Yu, Y., Deng, H., Wang, W., Xiao, S., Zheng, R., Lv, L., Wang, H., Chen, J., & Zhang, B. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1583 · Cited by 33
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers
Derouane, F., Desgres, M., Moroni, C., Ambroise, J., Berlière, M., Bockstal, M. V., Galant, C., van Marcke, C., Vara-Messler, M., Hutten, S. J., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01788-8 · Cited by 34
A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy
Ascheid, D., Baumann, M., Pinnecker, J., Friedrich, M., Szi-Marton, D., Medved, C., Bundalo, M., Ortmann, V., Öztürk, A., Nandigama, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48010-z · Cited by 32
Reimagining human-centric drug development with new approach methodologies
Wu, X., Wu, M. A., Zou, J., Kleinstreuer, N., & Wu, J. C. (2026) · Science · doi:10.1126/science.aeb0045 · Cited by 37
Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer
Roelofs, C., Hollande, F., Redvers, R. P., Anderson, R. L., & Mérino, D. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180375 · Cited by 32
Inflammatory Breast Cancer: a Separate Entity
Rosenbluth, J. M., & Overmoyer, B. A. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0842-y · Cited by 32
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
Giovanni, C. D., Nicoletti, G., Landuzzi, L., Palladini, A., Lollini, P., & Nanni, P. (2019) · Cancers · doi:10.3390/cancers11121889 · Cited by 32
Use of preclinical models for malignant pleural mesothelioma
Shamseddin, M., Obacz, J., Garnett, M. J., Rintoul, R. C., Francies, H. E., & Marciniak, S. J. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216602 · Cited by 30
Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography
Gil, D. A., Deming, D. A., & Skala, M. C. (2021) · Biomedical Optics Express · doi:10.1364/boe.428197 · Cited by 33
Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
Li, Z., Xu, H., Gong, Y., Chen, W., Zhan, Y., Yu, L., Sun, Y., Li, A., He, S., Guan, B., et al. (2021) · Advanced Science · doi:10.1002/advs.202103999 · Cited by 32
In-Depth Comparison of Matrigel Dissolving Methods on Proteomic Profiling of Organoids
Wang, M., Yu, H., Zhang, T., Cao, L., Du, Y., Xie, Y., Ji, J., & Wu, J. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100181 · Cited by 34
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Williams, S. T., Wells, G., Conroy, S., Gagg, H., Allen, R. J., Rominiyi, O., Helleday, T., Hullock, K., Pennington, C. E. W., Rantala, J., et al. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.32 · Cited by 35
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin
Saeki, S., Kumegawa, K., Takahashi, Y., Yang, L., Osako, T., Yasen, M., Otsuji, K., Miyata, K., Yamakawa, K., Suzuka, J., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01617-4 · Cited by 33
Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models
Abolhassani, H., Eskandari, A., Poor, A. S., Zarrabi, A., Khodadadi, B., Karimifard, S., Sahrayi, H., Bourbour, M., & Yaraki, M. T. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215754 · Cited by 35
The Transformative Role of 3D Culture Models in Triple-Negative Breast Cancer Research
Bittman-Soto, X. S., Thomas, E. S., Ganshert, M., Mendez‐Santacruz, L. L., & Harrell, J. C. (2024) · Cancers · doi:10.3390/cancers16101859 · Cited by 31
Refining Early Antitumoral Drug Development
Ocaña, A., García‐Alonso, S., Amir, E., & Pandiella, A. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.09.003 · Cited by 31
MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
Du, M., Lei, M., Han, Y., Zhao, D., Zhang, X., Yang, Y.-Y., & Liu, R. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s187221 · Cited by 31
Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine
Franco, G. D., Usai, A., Funel, N., Palmeri, M., Montesanti, I. E. R., Bianchini, M., Gianardi, D., Furbetta, N., Guadagni, S., Vasile, E., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i21.2792 · Cited by 31
The Progress and Clinical Application of Breast Cancer Organoids
Yu, J. S., & Huang, W. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc20082 · Cited by 32
High-resolution positron emission microscopy of patient-derived tumor organoids
Khan, S., Shin, J. H., Ferri, V., Cheng, N., Noel, J. E., Kuo, C. J., Sunwoo, J. B., & Pratx, G. (2021) · Nature Communications · doi:10.1038/s41467-021-26081-6 · Cited by 33
Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids
Wu, Y., Li, K., Li, Y., Sun, T., Liu, C., Dong, C., Zhao, T., Tang, D., Chen, X., Chen, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1201 · Cited by 31
O-linked α2,3 sialylation defines stem cell populations in breast cancer
Walker, M. R., Goel, H. L., Mukhopadhyay, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj9513 · Cited by 31
A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
Carter, M. E., Hartkopf, A. D., Wagner, A., Volmer, L. L., Brucker, S. Y., Berchtold, S., Lauer, U. M., & Koch, A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.826302 · Cited by 31
Amyloid fibril-based thixotropic hydrogels for modeling of tumor spheroids in vitro
Singh, N., Patel, K., Navalkar, A., Kadu, P., Datta, D., Chatterjee, D., Mukherjee, S., Shaw, R., Gahlot, N., Shaw, A., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122032 · Cited by 36
Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
Visalakshan, R. M., Lowrey, M. K., Sousa, M. G. C., Helms, H. R., Samiea, A., Schutt, C. E., Moreau, J. M., & Bertassoni, L. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162905 · Cited by 32
Simultaneous isolation of hormone receptor–positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms
Högström, J., Cruz, K. A., Selfors, L. M., Ward, M. N., Mehta, T. S., Kanarek, N., Philips, J., Dialani, V. M., Wulf, G. M., Collins, L. C., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105021 · Cited by 28
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
Li, M., Nishimura, T., Takeuchi, Y., Hongu, T., Wang, Y., Shiokawa, D., Wang, K., Hirose, H., Sasahara, A., Yano, M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166666 · Cited by 30
Deep Learning–Based 3D Single-Cell Imaging Analysis Pipeline Enables Quantification of Cell–Cell Interaction Dynamics in the Tumor Microenvironment
Liu, B., Zhu, Y., Yang, Z., Yan, H. H. N., Leung, S. Y., & Shi, J. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1100 · Cited by 31
Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
Khorsandi, D., Yang, J., Foster, S., Khosravi, S., Kouchehbaghi, N. H., Zarei, F., Lee, Y. B., Runa, F., Gangrade, A., Voskanian, L., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302331 · Cited by 33
Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arrays
Yakavets, I., Kheiri, S., Cruickshank, J., Hickman, R. J., Rakhshani, F., Aldeghi, M., Rajaonson, E. M., Young, E. W. K., Aspuru‐Guzik, A., Cescon, D. W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt1851 · Cited by 31
Multi-cellular engineered living systems: building a community around responsible research on emergence
Sample, M., Boulicault, M., Allen, C. R., Bashir, R., Hyun, I., Levis, M., Lowenthal, C., Mertz, D. R., Montserrat, N., Palmer, M. J., et al. (2019) · Biofabrication · doi:10.1088/1758-5090/ab268c · Cited by 29

Authors: Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., Korving, J., van Boxtel, R., Duarte, A. A., Lelieveld, D., van Hoeck, A., Ernst, R. F., Blokzijl, F., Nijman, I. J., Hoogstraat, M., van de Ven, M., Egan, D. A., Zinzalla, V., Moll, J., Boj, S. F., Voest, E. E., Wessels, L., van Diest, P. J., Rottenberg, S., Vries, R. G. J., Cuppen, E., & Clevers, H.
Affiliations: Royal Netherlands Academy of Arts and Sciences (NL)
The Netherlands Cancer Institute (NL)
University Medical Center Utrecht (NL)
Utrecht University (NL)
Boehringer Ingelheim (Austria) (AT)
Oncode Institute (NL)
University of Bern (CH)
Corresponding author: Clevers, Hans
ORCID: Sachs, Norman
Gogola, Ewa
Weeber, Fleur
Begthel, Harry
Ernst, Robert Frans
Blokzijl, Francis
Hoogstraat, Marlous
Boj, Sylvia Fernandez
Voest, Emile Eugene
Wessels, Lodewyk
Rottenberg, Sven
Vries, Robert Gerhardus Jacob
Cuppen, Edwin
Clevers, Hans
Venue: Cell
Publisher: Elsevier BV
Published: 2018-01
Volume: 172
Issue: 1-2
Pages: 373-386.e10
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2017.11.010
OpenAlex: W2773981699
Cited by: 1,973
References: 79
Citations by year: 2026: 219 · 2025: 240 · 2024: 288 · 2023: 251 · 2022: 274 · 2021: 259 · 2020: 238 · 2019: 127 · 2018: 74
FWCI: 53.62
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Bern Open Repository and Information System (University of Bern) (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion)
Funders: MKMD (114021012)
Netherlands Organization for Scientific Research (91615182, 114021012)
Stand Up to Cancer International Translational Cancer Research Grant
Stichting Vrienden van Hubrecht (2012.010)
Cancer Genomic Center (2014-186)
Boehringer-Ingelheim RCV GmbH & Co KG (141947)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords: breast cancer, organoid biobank, tumor heterogeneity, metastatic breast cancer, long-term organoid culture, copy number variation, gene expression subtypes, hormone receptor status, HER2 status, in vitro drug testing, xenotransplantation
MeSH terms: Animals, Antineoplastic Agents, Breast Neoplasms, Cells, Cultured, Drug Screening Assays, Antitumor, Female, Humans, Mice, Nude, Organoids, Tissue Banks, Genetic Heterogeneity, Mice, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks